What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Anti-corruption"

Search information

Kineta, Inc.

Companies

"Anti-corruption"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

33 results

Newest first Best match first

KANT Kineta, Inc.

ability to conduct its clinical trials, its development plans and business. Kineta is subject to certain U.S. and foreign anti-corruption, anti-money … anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations (collectively, “Trade Laws”) prohibit, among

21 Mar 24

4:06pm

KANT Kineta, Inc.

trials, its development plans and business. Kineta is subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control … , sanctions, and other trade laws and regulations. Kineta can face serious consequences for violations. U.S. and foreign anti-corruption, anti-money

31 Mar 23

4:05pm

KANT Kineta, Inc.

Kineta Completes Reverse Merger with Yumanity Therapeutics

to conduct its clinical trials, its development plans and business. Kineta is subject to certain U.S. and foreign anti-corruption, anti-money … laundering, export control, sanctions, and other trade laws and regulations. Kineta can face serious consequences for violations. U.S. and foreign anti

KANT Kineta, Inc.

Quarterly report

business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate

14 Nov 22

8:44am

KANT Kineta, Inc.

Prospectus supplement

laws. Yumanity’s business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

usv e0m5yr1zd0xh9

Quarterly report

4 Aug 22

5:12pm

Business combination disclosure

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

njs cvpce88urpgd5r

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

628xv2dps0pwbsfs5

Quarterly report

12 May 22

4:59pm

24 Mar 22

4:31pm

Shelf registration

3 Dec 21

4:15pm

e9u8urr4zsoob i3ruu

Quarterly report

15 Nov 21

7:51am

e6bu9viwu 8coxbkr918

Quarterly report

12 Aug 21

4:23pm

k7u0op7e tef3p0m2kan

Quarterly report

13 May 21

4:11pm

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.